![](https://www.brookings.edu/wp-content/uploads/2017/11/thp_20171120_rd.jpeg?quality=75&w=1000)
Assessing Pharma’s constraints, opportunities, and investment options in global health R&D: An analysis of SEC 10-K filings
Launched in 2016, the Brookings Private Sector Global Health R&D Project seeks to identify financial incentives to spur private sector investment in medications for developing countries in Asia and Africa.